Suicide is a public health problem, with multiple causes that are poorly understood. The increased focus on combining health care data with machine-learning approaches in psychiatry may help advance the understanding of suicide...
Read MoreEuthanasia and physician-assisted suicide (EAS) in psychiatry are permitted in the Netherlands under certain legal conditions. Doctors may help patients who suffer unbearably and who have no prospect of improvement from...
Read MoreRecent media reports have refocused attention on the syndromic manifestation experienced by some patients as they discontinue their antidepressant medication (“discontinuation syndrome”). This attention has been...
Read MoreOpioid addiction is a major public health problem. Despite availability of evidence-based treatments, relapse and dropout are common outcomes. Efforts aimed at identifying reuse risk and gaining more precise understanding of the...
Read MoreBy Lisa Rapaport People who smoke or have recently quit have higher odds of being severely impaired after a stroke than their counterparts who never smoked, a new study suggests. Smoking has long been linked to an increased risk...
Read MoreSignificantly more patients treated with Ubrelvy versus placebo achieved pain freedom two hours post-treatment TUESDAY, Dec. 24, 2019 (HealthDay News) — Ubrelvy (ubrogepant) tablets have been approved for acute treatment...
Read MoreThe longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes. THURSDAY, Dec. 26, 2019 (HealthDay News) — Buprenorphine treatment may be needed for several years after an opioid...
Read MorePublished: Dec 16, 2019 Potentially first-and-only, oral NMDA receptor antagonist with multimodal activity for the treatment of depression Company to host conference call today at 8:00 AM ET NEW YORK, Dec. 16, 2019 (GLOBE...
Read More
Pattern of damage seen in regions responsible for control of appetite, emotions, cognitive functions
Read More